We are live on ! Find out more
AEGR

Aegerion Pharmaceuticals
AEGR

Delisted

AEGR was delisted on the 29th of November, 2016.

Back to rankings

145 hedge funds and large institutions have $1.94B invested in Aegerion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 145 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $122M | Put options by funds: $90.3M

Holders
145
Holders Change
+145
Holders Change %
–
% of All Funds
4.73%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.13%
New
145
Increased
–
Reduced
–
Closed
–
Calls
$122M
Puts
$90.3M
Net Calls
+$31.3M
Net Calls Change
+$31.3M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$227M +$190M +3,586,776 New
PA
2
Perceptive Advisors
New York
$226M +$190M +3,573,426 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$225M +$189M +3,559,400 New
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$151M +$127M +2,384,299 New
JP Morgan Chase
5
JP Morgan Chase
New York
$103M +$86.7M +1,633,765 New
BFA
6
BlackRock Fund Advisors
California
$63M +$52.8M +994,775 New
BBA
7
Baker Bros. Advisors
New York
$58.5M +$49.1M +924,343 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$56.3M +$47.2M +889,556 New
AI
9
Advent International
Massachusetts
$55.6M +$46.6M +877,800 New
State Street
10
State Street
Massachusetts
$48.2M +$40.4M +761,239 New
SM
11
Sabby Management
Florida
$37.6M +$31.5M +593,862 New
BIT
12
BlackRock Institutional Trust
California
$37.5M +$31.4M +591,778 New
KCM
13
Kingdon Capital Management
New York
$31.7M +$26.5M +499,847 New
First Manhattan
14
First Manhattan
New York
$28.8M +$19.8M +373,105 New
Northern Trust
15
Northern Trust
Illinois
$25.4M +$21.3M +401,543 New
O
16
OppenheimerFunds
New York
$22.3M +$18.7M +351,470 New
PHS
17
PFM Health Sciences
California
$20M +$16.8M +315,931 New
CCI
18
Columbus Circle Investors
$19.9M +$16.7M +314,641 New
Millennium Management
19
Millennium Management
New York
$19.9M +$16.7M +314,142 New
JHIU
20
Janus Henderson Investors US
Colorado
$18.6M +$15.6M +293,289 New
CCM
21
Cupps Capital Management
Illinois
$18.3M +$15.3M +288,863 New
Deutsche Bank
22
Deutsche Bank
Germany
$17.9M +$15M +282,630 New
OAM
23
Oxford Asset Management
United Kingdom
$17M +$14.2M +268,029 New
TI
24
Turner Investments
Pennsylvania
$16.9M +$14.2M +267,500 New
UBS AM
25
UBS AM
Illinois
$16.5M +$13.9M +261,153 New
1
2 3 4 5

AEGR Hedge Fund Activity: Q2 2013 in Review

145 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Aegerion Pharmaceuticals (AEGR) for Q2 2013, worth a combined $1.94B.

Buyers outnumbered sellers: 145 funds opened new AEGR positions and 0 closed out — a net gain of 145 holders — while 0 added to existing stakes and 0 trimmed.

  • 145 institutional investors held Aegerion Pharmaceuticals (AEGR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.94B of Aegerion Pharmaceuticals stock for Q2 2013.
  • 145 funds opened new Aegerion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +145 holders.

Based on aggregated 13F filings for Q2 2013.